Medicine and Dentistry
Biological Marker
100%
Breast Cancer
100%
Immunoglobulin
100%
Tumor Infiltrating Lymphocyte
100%
Oncology
100%
Programmed Death 1 Ligand 1
50%
Immune Checkpoint Inhibitor
33%
Patient
33%
Comprehension
33%
Biological Product
16%
Exercise
16%
Immunotherapy
16%
Lymphocyte
16%
Malignant Neoplasm
16%
Triple Negative Breast Cancer
16%
Patient Advocate
16%
Analysis
16%
Inpatient
16%
Therapeutic Procedure
16%
Experience
16%
Survival
16%
Woman
16%
Examination
16%
Death
16%
INIS
cancer
100%
tumors
100%
biological markers
100%
breasts
100%
lymphocytes
100%
patients
57%
death
57%
ligands
42%
data
14%
testing
14%
information
14%
reviews
14%
income
14%
women
14%
utilities
14%
immunotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Neoplasm
100%
Immunoglobulin
100%
Biological Marker
100%
Programmed Death 1 Ligand 1
50%
Biological Product
16%
Immunotherapy
16%
Malignant Neoplasm
16%
Death
16%
Triple Negative Breast Cancer
16%
Survival
16%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Tumor-Infiltrating Lymphocytes
100%
Breast
100%
Programmed Death 1 Ligand 1
50%
Comprehension
33%
Immunity
33%
Immunotherapy
16%
Biological Product
16%
Lymphocyte
16%
Exercise
16%
Survival
16%
Experience
16%